The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
N
|
Novo Nordisk A/S
XHAM:NOV
|
DK |
|
Ternium SA
NYSE:TX
|
LU |
|
A
|
Albemarle Corp
F:AMC
|
US |
|
C
|
Carbonxt Group Ltd
ASX:CG1
|
AU |
|
C
|
Cloudflare Inc
XHAM:8CF
|
US |
|
Colonial SFL SOCIMI SA
OTC:IMQCF
|
ES |
|
Utah Medical Products Inc
NASDAQ:UTMD
|
US |
|
MGX Resources Ltd
ASX:MGX
|
AU |
|
H
|
Harim Co Ltd
KOSDAQ:136480
|
KR |
|
Vita Life Sciences Ltd
ASX:VLS
|
AU |
|
Banyan Gold Corp
XTSX:BYN
|
CA |
|
Vodacom Group Ltd
F:5VD0
|
ZA |
|
G
|
GoDaddy Inc
F:38D
|
US |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
Spineguard SA
F:6W5
|
FR |
|
M
|
McDonald's Holdings Company Japan Ltd
F:MJ8
|
JP |
|
Colonial SFL SOCIMI SA
F:HSC2
|
ES |
Kokuyo Co Ltd (7984)’s 12-month stock price forecast through October 2027 has a consensus target of ¥984.3, implying 13% upside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
Kokuyo Co Ltd is 984.3 JPY with a low forecast of 808 JPY and a high forecast of 1 155 JPY.
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 7%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 4%.
Over the last 13 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 5%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more